Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US
- Posted on March 7, 2025
- By Business News Today
- 3 Views
Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US
Biocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will supply the insulin, while Civica will manufacture and commercialize it, enhancing patient access to high-quality, affordable medication for diabetes management.
